ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Smart Halajko, Melissa C ^a   Kelley Hedgepeth, Alyson ^b   Montefusco, Maria C ^b   Cooper, Jackie A ^a   Kopin, Alan ^b   McCaffrey, Jeanne M ^c   Balasubramanyam, Ashok ^d   Pownall, Henry J ^d   Nathan, David M ^e   Peter, Inga ^f   Talmud, Philippa J ^a   Huggins, Gordon S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b TUFTS MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANGPTL4 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR DISEASE; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISPANIC; HOMOZYGOTE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WEIGHT REDUCTION; ALLELE; AMINO ACID SUBSTITUTION; BLOOD; CAUCASIAN; CLINICAL TRIAL; GENETICS; LIFESTYLE; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AGED; ALLELES; AMINO ACID SUBSTITUTION; ANGIOPOIETINS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HOMOZYGOTE; HUMANS; LIFE STYLE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRIGLYCERIDES; UNITED STATES;

EID: 79959674534     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-89     Document Type: Article

References (18)

1. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007, 115(4):450-458. 10.1161/CIRCULATIONAHA.106.637793, 17190864.
2. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004, 110(17):2678-2686.
3. Drexel H, Aczel S, Marte T, Benzer W, Langer P, Moll W, Saely CH. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?. Diabetes Care 2005, 28(1):101-107. 10.2337/diacare.28.1.101, 15616241.
4. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30(6):1374-1383. 2665929, 17363746.
5. Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, Henkin Y, Kochba I, Shai I. Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 2007, 147(6):377-385.
6. Picard F, Naimi N, Richard D, Deshaies Y. Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes 1999, 48(3):452-459. 10.2337/diabetes.48.3.452, 10078543.
7. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb 1991, 11(5):1192-1203.
8. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 2005, 33(Pt 5):1059-1062.
9. Sukonina V, Lookene A, Olivecrona T, Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 2006, 103(46):17450-17455. 10.1073/pnas.0604026103, 1859949, 17088546.
10. Yin W, Romeo S, Chang S, Grishin NV, Hobbs HH, Cohen JC. Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 2009, 284(19):13213-13222. 10.1074/jbc.M900553200, 2676053, 19270337.
11. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007, 39(4):513-516. 10.1038/ng1984, 2762948, 17322881.
12. Talmud PJ, Smart M, Presswood E, Cooper JA, Nicaud V, Drenos F, Palmen J, Marmot MG, Boekholdt SM, Wareham NJ, et al. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk. Arterioscler Thromb Vasc Biol 2008, 28(12):2319-2325. 10.1161/ATVBAHA.108.176917, 18974381.
13. Bray G, Gregg E, Haffner S, Pi-Sunyer XF, WagenKnecht LE, Walkup M, Wing R. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006, 3(3):202-215. 10.3132/dvdr.2006.031, 2660200, 17160917.
14. Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, Kahn SE, Knowler WC, Yanovski SZ. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003, 24(5):610-628. 10.1016/S0197-2456(03)00064-3, 14500058.
15. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006, 355(3):241-250. 10.1056/NEJMoa062418, 1762036, 16855264.
16. Pownall HJ, Brauchi D, Kilinc C, Osmundsen K, Pao Q, Payton-Ross C, Gotto AM, Ballantyne CM. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 1999, 143(2):285-297. 10.1016/S0021-9150(98)00301-3, 10217357.
17. Ge H, Yang G, Yu X, Pourbahrami T, Li C. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 2004, 45(11):2071-2079. 10.1194/jlr.M400138-JLR200, 15292369.
18. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009, 119(1):70-79. 2613476, 19075393.